GNH India Pharmaceuticals Ltd - Stock Valuation and Financial Performance

BSE: 0 | NSE: | Trading |

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on GNH India Pharma

DeciZen not available for IPO

10 Year X-Ray of GNH India Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'22Mar'23Mar'24TTM
ROCE % 28.1%35.2%26.3%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 22.632.3400
Sales YoY Gr.-43.4%23.8%-
Adj EPS 5.67.650
YoY Gr.-34.6%-34.8%-
BVPS (₹) 13.219.228.50
Adj Net
Profit
45.35NAN
Cash Flow from Ops. 1.5140.8-
Debt/CF from Ops. 7.20.80-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANANA23.8%
Adj EPS NANANA-34.8%
BVPSNANANA48.9%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'22Mar'23Mar'24TTM
Return on
Equity %
42.746.923.70
Op. Profit
Mgn %
25.625.719.4NAN
Net Profit
Mgn %
17.516.412.6NAN
Debt to
Equity
1.20.80-
Working Cap
Days
064590
Cash Conv.
Cycle
017130

Recent Performance Summary

Recent Performance Summary not available for IPO

Recent Performance Summary not available for IPO

Latest Financials - GNH India Pharmaceuticals Ltd.

Standalone Consolidated
TTM EPS (₹) - -
TTM Sales (₹ Cr.) - -
BVPS (₹.) - -
Reserves (₹ Cr.) - -
P/BV - -
PE - -
From the Market
52 Week Low / High (₹) - / -
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) -
Equity (₹ Cr.) -
Face Value (₹) -
Industry PE -

Management X-Ray of GNH India Pharma:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of GNH India Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24
Sales22.5532.3340.02
Operating Expenses 17.0924.3432.49
Manufacturing Costs0.031.150.08
Material Costs13.6819.3128.79
Employee Cost 0.240.280.43
Other Costs 3.153.603.19
Operating Profit 5.4687.53
Operating Profit Margin (%) 24.2%24.7%18.8%
Other Income 0.600.960.84
Interest 0.550.920.47
Depreciation 0.371.091.34
Exceptional Items 000
Profit Before Tax 5.146.946.56
Tax 1.311.771.68
Profit After Tax 3.835.174.87
PAT Margin (%) 17.0%16.0%12.2%
Adjusted EPS (₹)5.57.44.8
Dividend Payout Ratio (%)0%26%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 9.2413.4228.99
Share Capital 1110.16
Reserves 8.2412.4218.83
Minority Interest000
Debt11.0511.050
Long Term Debt11.0511.050
Short Term Debt000
Trade Payables0.081.610.25
Others Liabilities 3.2615.117.12
Total Liabilities 23.6341.1936.36

Fixed Assets

Gross Block16.3318.3218.45
Accumulated Depreciation0.371.462.80
Net Fixed Assets15.9616.8615.65
CWIP 00.640.83
Investments 000
Inventories0.974.071.33
Trade Receivables00.020.01
Cash Equivalents 515.0915.54
Others Assets1.694.523
Total Assets 23.6341.1936.36

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24
Cash Flow From Operating Activity 1.5413.960.79
PBT 5.146.946.56
Adjustment 0.681.331.01
Changes in Working Capital -3.097.28-5.18
Tax Paid -1.19-1.59-1.60
Cash Flow From Investing Activity -16.09-1.980.42
Capex -16.32-1.99-0.14
Net Investments 000
Others 0.230.010.56
Cash Flow From Financing Activity 11.41-1.88-0.77
Net Proceeds from Shares 0.9500
Net Proceeds from Borrowing 11.0500
Interest Paid -0.54-0.88-0.42
Dividend Paid -0.05-1-0.35
Others 000
Net Cash Flow -3.1410.100.44
PARTICULARSMar'22Mar'23Mar'24
Ratios
ROE (%)41.4945.6622.99
ROCE (%)28.0635.1526.29
Asset Turnover Ratio0.9511.03
PAT to CFO Conversion(x)0.42.70.16
Working Capital Days
Receivable Days000
Inventory Days162825
Payable Days21612

GNH India Pharmaceuticals Ltd Stock News

GNH India Pharmaceuticals Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of GNH India Pharma on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of GNH India Pharma stood at ₹0.00.
The latest P/E ratio of GNH India Pharma as of 01-Jan-1970 05:30 is 0.00.
The latest P/B ratio of GNH India Pharma as of 01-Jan-1970 05:30 is 0.00.
The 52-week high of GNH India Pharma is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of GNH India Pharma is ₹0.00 ( Cr.) .

About GNH India Pharmaceuticals Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.